ICER calls out JNJ and Bausch on its annual list of price hike offenders — Lilly tightens access to diabetes drug Mounjaro — Zimmer, Boston Sci set to lead positive med device pricing trend in 2023 -- See more on our front page news http://bit.ly/w28kSd #icer #drugpricing #pricehike #jnj #mounjaro #type2diabetes #elililly #meddevice #bostonscientific #zimmer #pricing #medtech #biotech #biotechnology #biopharma #pharma #pharmanews #cafepharm
#ICER #drugpricing #pricehike #jnj #mounjaro #type2diabetes #elililly #MedDevice #bostonscientific #zimmer #pricing #medtech #biotech #biotechnology #biopharma #pharma #pharmanews #cafepharm